We alternatively converted a potent p300 inhibitor into a bivalent small molecule that leverages chemical induced proximity (CIP) to redirect p300/CBP acetyltransferase activity, triggering cell death in diffuse large B-cell lymphomas. The gene discussed is EP300; the disease is diffuse large B-cell lymphoma.